Regeneron Pharmaceuticals Q3 adjusted earnings Beat Estimates
WASHINGTON (dpa-AFX) - Regeneron Pharmaceuticals (REGN) released earnings for its third quarter that advanced from the same period last year.The company's earnings totaled $1.63 billion, or $14.33